Lenvatinib en Cáncer Diferenciado de Tiroides: Respuestas tras la Refractariedad al Radioyodo - page 14

Best Tumor Response

CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease.

Median tumor

shrinkage for

responders (range):

-52%

(-100%, -30%)

RR: 65%

Schlumberger M, et al.

N Engl J Med

2015

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,4,5,6,7,8,9,10,11,12,13 15,16,17,18,19,20,21,22,23,24,...27